Diabetes Drug Shows Promise Against MS

Source: University of Illinois at Chicago Office of Public Affairs, Press Release
A drug currently FDA-approved for use in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis, researchers at the University of Illinois at Chicago College of Medicine report in a study currently available online in the Journal of… »

Marijuana Chemical May Slow MS

Temple University researchers are studying more effective ways to treat multiple sclerosis. And their research utilizes synthetic cannabinoids based on chemicals derived from the marijuana… »

FDA Assigns Priority Review for Fampridine-SR

Source: Acorda Therapeutics Press Release
Acorda Therapeutics Announces FDA Acceptance of Fampridine-SR New Drug Application for Filing
FDA Assigns Priority Review and PDUFA Date of October 22, 2009
No Current Therapies Indicated to Improve Walking Ability in People with MS
HAWTHORNE, N.Y., May. 6, 2009-Acorda Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the… »

Merck Reports Oral MS Drug Effective

Merck Press Release:
Two-Year Phase III Data Presented at AAN 61st Annual Meeting Show Positive Outcome of Cladribine Tablets in Patients with Multiple Sclerosis

Primary endpoint met with a significant reduction in relapse rate
Secondary endpoints met including MRI measures, proportion of patients relapse-free and disability progression
Submission for registration of Cladribine Tablets planned for mid-2009

Seattle, WA, United States/… »